KARIN EASTHAM
CIK 1231845 · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.38M
Companies
10
Total Filings
157
Lifetime Open-Market Net
-$168.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCYT | Director | 19,826 | $47.22 | $936.2K | -$150.29M | 31 | 2026-06-22 |
| PSNL | Director | 19,756 | $14.16 | $279.7K | $0 | 9 | 2026-06-11 |
| GERN | Director | 109,047 | $1.48 | $161.4K | $0 | 22 | 2023-01-17 |
| NKTR | Director | 1,549 | $76.48 | $118.5K | -$76.8K | 7 | 2022-09-20 |
| ILMN | Director | 10,049 | $187.96 | $1.89M | -$18.46M | 34 | 2019-05-28 |
| Trius Therapeutics Inc (TSRX) Delisted | Director | 18,114 | — | — | $0 | 6 | 2013-05-23 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 6,000 | — | — | $0 | 19 | 2012-05-17 |
| GENOPTIX INC (GXDX) Delisted | Director | 0 | — | — | $0 | 10 | 2011-03-07 |
| SGX PHARMACEUTICALS, INC. (SGXP) Delisted | Director | 0 | — | — | $0 | 4 | 2008-08-21 |
| TERCICA INC (TRCA) Delisted | Director | 13,333 | $7.87 | $104.9K | $0 | 2 | 2008-05-21 |
Recent Filings · Page 15 of 16
157 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-06-11 | SGX PHARMACEUTICALS, INC. (SGXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-04 | ILMN | Mixed | — | -$738.8K | EDGAR |
| 2008-05-30 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-21 | TERCICA INC (TRCA) Delisted | Grant (A) | +3,333 | $0 | EDGAR |
| 2008-05-20 | ILMN | Grant (A) | +1,000 | $0 | EDGAR |
| 2008-04-04 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-01-14 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-10-09 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-07-25 | ILMN | Grant (A) | — | $0 | EDGAR |
| 2007-07-10 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.